The introduction of the B.Pharm. programme marks a significant milestone in the University's expansion of professional education in the healthcare domain. Backed by approval from the apex statutory body for pharmacy education in India, the programme is designed to prepare competent pharmacy professionals with scientific knowledge, practical skills, research aptitude, and ethical values to meet the evolving requirements of the healthcare and pharmaceutical sectors.
The School of Pharmaceutical Sciences at MUJ offers state-of-the-art infrastructure to support experiential learning and research. Students will have access to advanced laboratories, smart classrooms, seminar halls, modern research facilities, and the University's academic ecosystem. The programme is further supported by Manipal University Jaipur's focus on innovation, interdisciplinary learning, industry engagement, and holistic student development.
Drawing on the Manipal Group's distinguished legacy of over 70 years in healthcare, education, and research, the programme aims to nurture future-ready professionals capable of contributing to the pharmaceutical industry, healthcare institutions, regulatory organizations, clinical research, academia, and entrepreneurship.
The curriculum has been designed to combine strong theoretical foundations with laboratory training, industry exposure, and research-oriented learning. It aims to ensure that graduates are prepared for emerging opportunities in the rapidly growing pharmaceutical and life sciences sectors.
The University believes that the new programme will provide aspiring students with a platform to build careers in pharmaceutical manufacturing, quality assurance, drug development, clinical research, hospital pharmacy, regulatory affairs, public health, and healthcare innovation.
Speaking on the occasion, Prof. (Dr.) N. N. Sharma, President, Manipal University Jaipur, said, "The launch of the PCI-approved B.Pharm. programme is another important step in strengthening our commitment to excellence in healthcare education. With the Manipal legacy, world-class infrastructure, experienced faculty, and a research-driven learning environment, we are confident that our students will emerge as competent professionals capable of making meaningful contributions to society and the healthcare ecosystem."
The University has invited aspiring students interested in pharmaceutical sciences, healthcare, research, and innovation to apply for the programme. Admissions for the 2026–27 academic session are currently underway.
Manipal University Jaipur is one of India’s leading multidisciplinary universities, known for academic excellence, innovation, research, and industry-oriented education. Established in 2011 as part of the prestigious Manipal Education and Medical Group (MEMG), MUJ has emerged as a destination for higher education, offering a learning ecosystem focused on knowledge, creativity, leadership, and entrepreneurship.
Accredited with an A+ Grade by NAAC, MUJ offers undergraduate, postgraduate, doctoral, and professional programmes across Engineering, Management, Law, Design, Architecture, Commerce, Arts, Science, Humanities, Journalism, and Allied Health Sciences. The University emphasizes experiential learning, interdisciplinary education, research excellence, innovation, and global engagement.
With a student community representing almost every state and union territory of India, along with several international students, MUJ promotes diversity, inclusivity, and cultural exchange. Through its commitment to quality education, impactful research, sustainability, and social responsibility, Manipal University Jaipur continues to empower future-ready professionals and responsible global citizens.
The launch of the PCI-approved B.Pharm. programme adds pharmaceutical education to MUJ's academic offerings and provides aspiring students an opportunity to pursue professional education in pharmaceutical sciences during the 2026–27 academic session.
About The Author
.jpg)
Comment List